These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3743657)

  • 21. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides.
    Pejler G; Danielsson A; Björk I; Lindahl U; Nader HB; Dietrich CP
    J Biol Chem; 1987 Aug; 262(24):11413-21. PubMed ID: 3624220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
    Danishefsky I; Ahrens M; Klein S
    Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation.
    Ruzicka K; Wojta J; Artemiou O; Birsan T; Quehenberger P; Kapiotis S; Hofbauer R; Speiser W
    Life Sci; 1998; 63(17):1493-503. PubMed ID: 9808060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
    Höök M; Björk I; Hopwood J; Lindahl U
    FEBS Lett; 1976 Jul; 66(1):90-3. PubMed ID: 1278445
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.
    Kusche M; Hannesson HH; Lindahl U
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):151-8. PubMed ID: 1902083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.
    Petersen LC; Jørgensen M
    Biochem J; 1983 Apr; 211(1):91-7. PubMed ID: 6870832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.
    Horner AA
    Biochem J; 1989 Sep; 262(3):953-8. PubMed ID: 2590178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of collagen on thrombin inactivation by antithrombin-III and heparin.
    Blaskó G; Bédi J; Machovich R; Pálos LA
    Haematologia (Budap); 1977; 11(1-2):163-8. PubMed ID: 615087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of heparin on thrombin-antithrombin reaction.
    Machovich R; Blaskó G; Pálos LA
    Biochim Biophys Acta; 1975 Jan; 379(1):193-200. PubMed ID: 1115795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of glycosaminoglycans from cultures of human skin fibroblasts.
    Gill PJ; Adler J; Silbert CK; Silbert JE
    Biochem J; 1981 Jan; 194(1):299-307. PubMed ID: 7305984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism.
    Jordan RE
    Arch Biochem Biophys; 1983 Dec; 227(2):587-95. PubMed ID: 6607710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin with two binding sites for antithrombin or platelet factor 4.
    Jordan RE; Favreau LV; Braswell EH; Rosenberg RD
    J Biol Chem; 1982 Jan; 257(1):400-6. PubMed ID: 7053378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 40. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.